Status:
COMPLETED
The Promotion Plan of Moxibustion on Ulcerate Colitis
Lead Sponsor:
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To evaluate the efficacy of Moxibustion in the treatment of Ulcerative Colitis, thus the scientific foundation for rational use of Moxibustion in clinical usage, in order to find admission of the Acup...
Detailed Description
A total of 128 patients with UC were randomly divided into the following 2 groups: a) Herb-partition moxibustion (Treatment Group) and b) Sham herb-partition moxibustion (Control Group). All patients ...
Eligibility Criteria
Inclusion
- Meet the diagnosis of UC
- Patients do not receive any medicine, or if they are receiving medicine, it should be aminosalicylates and/or prednisone (dose ≤15mg and have taken at least 1 month);
- Patients should have not received antibiotic, biologicals within 3 months prior to entering the study;
- Signing a written informed consent.
Exclusion
- Patients with cardiac, encephalic, hepatic, nephric, hematopoietic system, psychotic or any other serious diseases;
- Pregnancy or lactation;
- genetic family history of nervous system disease
Key Trial Info
Start Date :
November 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT03232528
Start Date
November 1 2016
End Date
December 30 2019
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Research Insititute of Acupuncture and Meridian
Shanghai, Xuhui, China, 20000